A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...

FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign to have him fired. We may earn a ...

Dr. Vinay Prasad has been reinstated as the FDA's top vaccine regulator after resigning due to pressure from biotech executives and Trump allies. Known for his critical stance on drug approvals, ...

Robby Soave and Lindsey Granger discuss the rehiring of Vinay Prasad as FDA top vaccine regulator. #vinayprasad #fda ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from enabling innovation to second-guessing it. Alongside figures ...

The drastic cost-cutting move follows the deaths of two teenagers that forced the company to restrict usage of its gene therapy for Duchenne muscular dystrophy.

The FDA’s other main drug review office, the Center for Biologics Evaluation and Research, is run by Vinay Prasad, a physician researcher and longtime critic of the agency who Makary appointed ...

In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA’s COVID response, to run the agency’s vaccine center. He was also named to the post of FDA chief medical officer.

Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs.